ClinicalTrials.gg
RecruitingNCT06713291Updated Apr 2, 2026

Clinical Study of a Novel Sliding Compression Locking Plate in the Treatment of Fresh Femoral Neck Fractures

An interventional study of Sliding compression locking plate and Three cannulated compression screws in Fracture of Femoral Neck, sponsored by Chinese PLA General Hospital. Recruiting at 3 sites in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-02.

Sponsored by Chinese PLA General Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Dec 2024; still recruiting 1 year 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,150
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 22 studies in Femoral Neck Fractures with a site in China — 7 open to participants now, 7 under way, none of them phase 3. Femoral Neck Fractures · China.

Planned enrollment
Largest of 20
1,150 · median 118
Started
2024
with 3 others
No phase
18 of 22
5 open now
Registered
16th of 22
by date
Lead sponsor
4 of 22
Chinese PLA General Hospital

Among the 22 studies in Femoral Neck Fractures with a site in China, this one has the largest planned enrollment of the 20 interventional ones that give a count, is one of 4 that started in 2024, is one of 18 with no phase, and was the 16th registered.

Femoral Neck Fractures

207 studies on the registry are indexed under Femoral Neck Fractures; 40 are open to participants now.

Browse Femoral Neck Fractures studies →

Open to participants now

7 of the 22 studies in Femoral Neck Fractures with a site in China are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 23 Femoral Neck Fractures studies recruiting now, 16 (70%) set no upper age limit and 4 (17%) stop at 75 or younger; 1 takes children under 18; 1 takes healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 22 studies in Femoral Neck Fractures with a site in China, or all of them as a file.
02

Study summary

To verify the safety and efficacy of sliding compression locking plates in the treatment of fresh femoral neck fractures

03

Conditions studied

  • Fracture of Femoral Neck

Keywords

  • fracture of neck of femur, sliding compression locking plate, compression screws
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age >=18 years old, gender is not limited;
  2. Patients diagnosed with femoral neck fracture;
  3. Patients with indications for internal fixation of femoral neck fracture and able to tolerate surgery;
  4. The subject or his legal representative is informed of the nature of the study and agrees to participate in the study.

Exclusion criteria

Exclusion Criteria:

  1. Participants who had participated in clinical studies of other drugs, biologics or medical devices before enrollment and did not reach the primary study endpoint time limit;
  2. The patient is known to have a history of allergy to one or more implanted materials;
  3. Patients determined by researchers to be physically weak or unable to tolerate surgery due to other systemic diseases;
  4. Active infection of the hip joint or other parts of the body is determined by the investigator;
  5. Diagnosed as metabolic bone disease, radiation bone disease, etc.;
  6. Severe hip contracture deformity or severe muscle loss fused to the functional position for a long time without pain;
  7. have inflammatory arthritis, such as rheumatoid arthritis, systemic lupus erythematosus arthritis, ankylosing spondylitis, etc.;
  8. The patient is mentally incapable or unable to understand the requirements of participating in the study, and it is difficult to cooperate;
  9. Other conditions deemed unsuitable for inclusion by the investigator.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
1,150 participants (estimated)

Study arms

  • Experimental
    Sliding compression locking plate

    Patients with femoral neck fracture were treated with sliding compression locking plate internal fixation.

    Procedure: Sliding compression locking plate

  • Placebo comparator
    Three cannulated compression screws

    The patients with femoral neck fracture were treated with three cannulated compression screws.

    Procedure: Three cannulated compression screws

Interventions

  • ProcedureSliding compression locking plate

    The patients with femoral neck fracture were treated with three cannulated compression screws or sliding compression locking plate.

  • ProcedureThree cannulated compression screws

    The patients with femoral neck fracture were treated with three cannulated compression screws.

06

What researchers measure

Primary outcomes

  1. Femoral neck shortened

    The difference in femoral neck length between 1 week post-surgery and 6 months and 12 months post-surgery, measured via X-ray and CT imaging examinations.

    Time frame: 1 year

Secondary outcomes

  1. Neck shaft angle

    Time frame: 1 year

  2. The effectiveness of guide pin implantation

    For the cohort treated with three cannulated compression screws, the effectiveness of guide pin implantation is categorized into three parallel, two parallel, and non-parallel arrangements,which will be measured during the surgery.

    Time frame: 1 day

  3. Time of operation

    Time frame: 1 day

  4. Blood loss

    Time frame: 1 day

  5. Bone union

    Time frame: 1 year

  6. Zarit Burden Interview(ZBI)

    The Zarit Burden Interview (ZBI) is a commonly used assessment tool designed to quantify the psychological and emotional burden experienced by caregivers who provide care for individuals with cognitive or functional impairments. Developed by Zarit and colleagues, the scale consists of 22 items that cover various aspects of caregiver burden, such as time pressure, emotional strain, and social isolation. The scoring ranges from 0 to 88, with higher scores indicating a greater level of caregiving burden. This tool aids healthcare professionals in identifying the psychological stress faced by caregivers and provides appropriate support and interventions to improve their mental health and quality of life.

    Time frame: 1 year

  7. SF-36 Score

    The SF-36 (Short Form 36 Health Survey) is a widely used generic health status assessment tool developed by the Medical Outcomes Study (MOS) Group. The scale is designed to comprehensively evaluate health-related quality of life, encompassing eight dimensions: physical functioning, social functioning, role limitations due to physical health, role limitations due to emotional problems, bodily pain, mental health, vitality, and general health perceptions. Each dimension consists of several items, and scores are derived by summing the scores of these items, typically converted to a 0 to 100 percent scale, with 100 representing the best possible health state. These eight dimension scores can be combined to form two summary scores: the Physical Component Summary (PCS) and the Mental Component Summary (MCS).

    Time frame: 1 year

  8. Harris Hip Score:

    The Harris Hip Score is a clinician-reported outcome measure assessing hip function, including pain, function, absence of deformity, and range of motion, used to evaluate outcomes after hip surgery.

    Time frame: hip function is assessed during outpatient follow-up at 1, 3, 6, and 12 months postoperatively using the Harris Hip Score system.

07

Study locations

2 of 3 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2024 (actual). Primary completion is estimated for Oct 2026, 22 months after the start.

Of 63 non-industry interventional studies with no phase under Femoral Neck Fractures, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 62. This study's planned 22 months is below that.

Counting every sponsor, half of 69 studies reached it within 46 months; a quarter within 25 and three quarters within 63.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 16, 2024
First posted
Dec 3, 2024
StartActual
Dec 10, 2024
Primary completionEst.
Oct 31, 2026
CompletionEst.
Oct 31, 2026
Last update
Apr 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06713291
Responsible party
Zhang Wei (Professor, Chinese PLA General Hospital) — Principal investigator
First posted
Dec 3, 2024
Start date
Dec 10, 2024
Primary completion
Oct 31, 2026 (estimated)
Completion
Oct 31, 2026 (estimated)
Last update
Apr 2, 2026

Study contacts

Wei Zhang
Contact
bszw@hotmail.com
+8618612409252

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion